Osteoarthritis: Prevention Strategies, Novel Diagnostics and Therapeutic Approaches and Burden Caused
A special issue of Healthcare (ISSN 2227-9032).
Deadline for manuscript submissions: 30 April 2025 | Viewed by 60
Special Issue Editor
Interests: sustainable development; orthopedics; environmental protection; three-dimensional printing
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Osteoarthritis (OA) is without a doubt the most prevalent joint disease worldwide. It represents major health problem due to an increasing older population with higher life expectancy, associated comorbidities such as obesity, and, more recently, limited access to medical care due to various situations such the COVID-19 pandemic, all contributing to the global burden of this disease. Recent therapeutic approaches aim to reverse and decelerate cartilage damage as joint arthroplasties have a high healthcare resource input and are the ultimate therapeutic choice. Novel non-operative strategies such as disease-modifying osteoarthritis drugs (DMOADs), autologous bone marrow cells (BMACs), and adipose-derived stromal cells (ADSCs) have been proposed to modify essential structures in the osteoarthritic joint. Tissue engineering represents another research direction in development that promises to restore the damaged articular cartilage with the use of biomaterials and genes. This Special Issue aims to highlight contributions focused on new advances for osteoarthritis prevention strategies and novel diagnostic and therapeutic approaches that can also reduce the overall burden of this disease. Original research articles and reviews are welcome. Research areas may include, but are not limited to, the following:
- Updates on novel non-operative treatment strategies for osteoarthritis;
- 3D bioprinting techniques for osteochondral regeneration;
- Disease-modifying osteoarthritis drug (DMOAD) development;
- Regenerative orthopedics and joint preservation;
- Epidemiology and burden of osteoarthritis.
I look forward to receiving your contributions.
Dr. Flaviu Moldovan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hip osteoarthritis
- knee osteoarthritis
- regenerative medicine
- tissue scaffolds
